Methicillin-resistant Staphylococcus aureus control: We didn't start the fire, but it's time to put it out

Infection Control and Hospital Epidemiology

Volumn 27, Issue 2, 2006, Pages 111-115

  Muto, Carlene A ^a,b,c  

^a PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; CHLORHEXIDINE; LIPOVITELLIN; MANNITOL; OFLOXACIN; OXACILLIN; PLACEBO; PSEUDOMONIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SODIUM CHLORIDE; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIUM CULTURE; CLINICAL TRIAL; COST BENEFIT ANALYSIS; EDITORIAL; HEALTH CARE; HUMAN; MEDICAL EDUCATION; MEDICAL INSTRUMENTATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; POLYMERASE CHAIN REACTION; PREVALENCE; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SEVERE ACUTE RESPIRATORY SYNDROME; SKIN INFECTION; SMALLPOX; SOFT TISSUE INFECTION; STAPHYLOCOCCUS INFECTION; TOXIC EPIDERMAL NECROLYSIS;

CROSS INFECTION; HUMANS; METHICILLIN RESISTANCE; STAPHYLOCOCCUS AUREUS; UNITED STATES;

EID: 33644916385     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/501489     Document Type: Editorial

References (55)

1. Centers for Disease Control and Prevention. Proportion of healthcare-acquired S. aureus infections resistant to oxacillin (MRSA) among ICU patients, 1989-2003. Vol. 2004. Available at: http://www.cdc.gov/ncidod/dhqp/ ar_mrsa.html. Accessed January 25, 2006.
2. Centers for Disease Control and Prevention. National Nosocomial Infections Surveillance (NNIS) system report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004; 32:470-485.
3. Centers for Disease Control and Prevention. Campaign to prevent antimicrobial resistance in healthcare settings: why a campaign? 2001. Available at: http://www.cdc.gov/drugresistance/healthcare/problem.htm. Accessed January 27, 2006.
4. Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y. Comparsion of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bactermia: a meta-analysis. Clin Infect Dis 2003; 36:53-59.
5. Engemann J, Carmeli Y, Cosgrove SE, et al. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infections. Clin Infect Dis 2003; 36: 592-598.
6. Centers for Disease Control and Prevention (CDC). Vancomycin-resistant Staphylococcus aureus-New York, 2004. MMWR Morb Mortal Wkly Rep 2004; 53:322-323.
7. Muto CA. Why are antibiotic-resistant nosocomial infections spiraling out of control? Infect Control Hosp Epidemiol 2005; 26:10-12.
8. Muto CA, Jernigan JA, Ostrowksy BE, et al. SHEA Guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus. Infect Control Hosp Epidemiol 2003; 24:362-386.
9. Lucet JC, Chevert S, Durand-Zaleski I, Chastang C, Regnier B. Multicenter Study Group. Prevalence and risk factors for carriage of methicillin-resistant Staphylococcus aureus at admission to the intensive care unit: results of a multicenter study. Arch Intern Med 2003; 163:181-188.
10. Boyce JM, Havill NL, Kohan C, Dumigan DG, Ligri CE. Do infection control measures work for methicillin-resistant Staphylococcus aureus? Infect Control Hosp Epidemiol 2004; 25:395-401.
11. Salgado CD, Farr BM. What proportion of hospital patients colonized with methicillin-resistant Staphylococcus aureus are identified by clinical microbiological cultures? Infect Control Hosp Epidemiol 2006; 27:116-121 (in this issue).
12. Eveillard M, de Lassence A, Lancien E, Barnaud G, Ricard JD, Joly-Guillou ML. Evaluation of a strategy of screening multiple anatomical sites for methicillin-resistant Staphylococcus aureus at admission to a teaching hospital. Infect Control Hosp Epidemiol 2006; 27:181-184 (in this issue).
13. Sandri AM, Dalarosa MG, de Alcântara LR, da Silva Elias L, Zavascki AP. Reduction in incidence of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection in an intensive care unit: role of treatment with mupirocin ointment and chlorhexidine baths for nasal carriers of MRSA. Infect Control Hosp Epidemiol 2006; 27:185-187 (in this issue).
14. Lucet JC, Grenet K, Armond-Lefevre L, et al. High prevalence of carriage of methicillin-resistant Staphylococcus aureus at hospital admission in elderly patients: implications for infection control strategies. Infect Control Hosp Epidemiol 2005; 26:121-126.
15. Goldstein FW, Acar JF. Epidemiology of quinolone resistance: Europe and North and South America. Drugs 1995; 49:36-42.
16. Safdar N, Narans L, Gordon B, Maki DG. Comparison of culture screening methods for detection of nasal carriage of methicillin-resistant Staphylococcus aureus: a prospective study comparing 32 methods. J Clin Microbiol 2003; 41:3163-3166.
17. Blair EB, Emerson JS, Tull AH. A new medium, salt mannitol plasma agar, for the isolation of Staphylococcus aureus. Am J Clin Pathol 1967; 47:30-39.
18. Chapman GH. The significance of sodium chloride in studies of staphylococci. J Bacteriol 1945; 50:201-203.
19. La Zonby JG, Starzyk MJ. Screening method for recovery of methicillin-resistant Staphylococcus aureus from primary plates. J Clin Microbiol 1986; 24:186-188.
20. Merlino J, Gill R, Robertson GJ. Application of lipovitellin-salt- mannitol agar for screening, isolation, and presumptive identification of Staphylococcus aureus in a teaching hospital. J Clin Microbiol 1996; 34:3012-3015.
21. van Enk RA, Thompson KD. Use of a primary isolation medium for recovery of methicillin-resistant Staphylococcus aureus. J Clin Microbiol 1992; 30:504-505.
22. Gorss EB. Prospective, focused surveillance for oxacillin-resistant Staphylococcus aureus. In: Isenberg IHD, ed. Clinical microbiology procedures handbook. Washington, DC: American Society for Microbiology; 1992: 11.15.1-11.15.2.
23. Singh K, Gavin PJ, Vescio T, et al. Microbiologic surveillance using nasal cultures alone is sufficient for detection of methicillin-resistant Staphylococcus aureus isolates in neonates. J Clin Microbiol 2003; 41:2755-2757.
24. Sanford MD, Widmer AF, Bale MJ, Jones RN, Wenzel RP. Efficient detection and long-term persistence of the carriage of methicillin-resistant Staphlyococcus aureus. Clin Infect Dis 1994; 19:1123-1128.
25. Papia G, Louie M, Tralla A, Johnson C, Collins V, Simor AE. Screening high-risk patients for methicillin-resistant Staphylococcus aureus on admission to the hospital: is it cost effective? Infect Control Hosp Epidemiol 1999; 20:473-477.
26. Shahin R, Johnson IL, Jamieson F, McGeer A, Tolkin J, Ford-Jones EL. Methicillin-resistant Staphylococcus aureus carriage in a child care center following a case of disease. Arch Pediatr Adolesc Med 1999; 153:864-868.
27. Sa-Leau R, Sanches IS, Couto I, Alves CR, de Lencastre H. Low prevalence of methicillin-resistant strains among Staphylococcus aureus colonizing young and healthy members of the community in Portugal. Microbial Drug Resistance 2001; 7:237-245.
28. Rihn JA, Michaels MG, Harner CD. Community-acquired methicillin-resistant Staphylococcus aureus: an emerging problem in the athletic population. Am J Sports Med 2005; 33:1924-1929.
29. Flayhart D, Hindler JF, Bruckner DA, et al. Multicenter evaluation of BBL CHROMagar MRSA medium for direct detection of methicillin-resistant Staphylococcus aureus from surveillance cultures of the anterior nares. J Clin Microbiol 2005; 43:5536-5540.
30. Warren DK, Liao RS, Merz LR, Eveland M, Dunne WM, Jr. Detection of methicillin-resistant Staphylococcus aureus directly from nasal swab specimens by a real-time PCR assay. J Clin Microbiol 2004; 42:5578-5581.
31. Check W. Border patrol: MRSA admission screening. CAP Today 2005; 19. Available at: http://www.cap.org/apps/docs/cap_today/cover_stories/ 1005_MRSA_Admission_Screening.html. Accessed January 30, 2006.
32. Back NA, Linnemann CC Jr, Staneck JL, Kotagal UR. Control of methicillin-resistant Staphylococcus aureus in a neonatal intensive-care unit: use of intensive microbiologic surveillance and mupirocin. Infect Control Hosp Epidemiol 1996; 17:227-231.
33. Struelens MJ, Ronveaux O, Jans B, Mertens R, the Groupement pour le Depistage, 'Etude et la Prevention des Infections Hospitalieres. Methicillin-resistant Staphylococcus aureus epidemiology and control in Belgian hospitals, 1991 to 1995. Infect Control Hosp Epidemiol 1996; 17:503-508.
34. Karchmer TB, Jernigan JA, Durbin BM, Simonton BM, Farr BM. Eradication of methicillin-resistant S. aureus (MRSA) colonization with different regimens. Program and Abstracts of the Ninth Annual Meeting of The Society for Healthcare Epidemiology of America- San Francisco, CA, April 18-20 1999. Abstract 65, p. 42.
35. Kotilainen P, Routamaa M, Peltonen R, et al. Eradication of methicillin-resistant Staphylococcus aureus from a health center ward and associated nursing home. Arch Intern Med 2001; 161:859-863.
36. Kluytmans J, Mouton JW. IJzerman EPF, et al. Reduction of surgical-site infections in cardiothoracic surgery by elimination of nasal carriage of Staphylococcus aureus. Infect Control Hosp Epidemiol 1996; 17:780-785.
37. Kluytmans JA, Manders MJ, van Bommel E, Verbrugh H. Elimination of nasal carriage of Staphylococcus aureus in hemodialysis patients. Infect Control Hosp Epidemiol 1996; 17:793-797.
38. Weber S, Herwaldt LA, Mcnutt LA, et al. An outbreak of Staphylococcus aureus in a pediatric cardiothoracic surgery unit. Infect Control Hosp Epidemiol 2002; 23:77-81.
39. Doebbeling BN, Breneman DL, Neu HC, et al. Elimination of Staphylococcus aureus nasal carriage in health care workers: analysis of six clinical trials with mupirocin calcium ointment. The Mupirocin Collaborative Study Group. Clin Infect Dis 1993; 17:466-474.
40. Doebbeling BN, Regan DR, Pfaller MA, Houston AK, Hollis RJ, Wenzel RP. Long term efficacy of intranasal mupirocin ointment. A prospective cohort study of Staphylococcus aureus carriage. Arch Intern Med 1994; 154:1505-1508.
41. Harbarth S, Dharan S, Liassine N, Herrault P, Auckenthaler R, Pittet D. Randomized, placebo-controlled, double-blind trial to evaluate the efficacy of mupirocin for eradicating carriage of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 1999; 43:1412-1416.
42. Harbarth S, Dharan S, Liassine N, Herrault P, Auckenthaler R, Pittet D. Risk factors for persistent carriage of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2000; 31:1380-1385.
43. Walker ES, Vasquez JE, Dula R, Bullock H, Sarubbi FA. Mupirocin-resistant, methicillin-resistant Staphylococcus aureus: does Mupirocin remain effective? Infect Control Hosp Epidemiol 2003; 24:342-346.
44. Semret M, Miller MA. Topical mupirocin for eradication of MRSA colonization with mupirocin-resistant strains. Infect Control Hosp Epidemiol 2001; 229:578-580.
45. Vasquez JE, Walker ES, Franzus BW, Overbay BK, Regan DR, Sarubbi FA. The epidemiology of mupirocin resistance among methicillin-resistant Staphylococcus aureus at a Veterans' Affairs hospital. Infect Control Hosp Epidemiol 2000; 21:459-464.
46. Miller MA, Dascal A, Portnory J, Medelson J. Development of mupirocin resistance among methicillin-resistant Staphyloccus aureus after widespread use of nasal mupirocin ointment. Infect Control Hosp Epidemiol 1996; 17:811-813.
47. Netto dos Santos K, de Souza FL, Gontijo Filho P. Emergence of high-level mupirocin resistance in methicillin-resistant Staphylococcus aureus isolated from Brazilian university hospitals. Infect Control Hosp Epidemiol 1996; 17:813-816.
48. Vivoni AM, Santos KR, de-Oliveira MP, et al. Mupirocin for controlling methicillin-resistant Staphylococcus aureus: lessons from a decade of use at a university hospital. Infect Control Hosp Epidemiol 2005; 26:662-667.
49. Praz SM, de Torrente A, Zender H, Schmied E, Schleppy CA, Genne D. Toxic epidermal necrolysis after topical intranasal application of mupirocin. Infect Control Hasp Epidemiol 2003; 24:459-460.
50. Loeb M, Main C, Walker-Dilks C, Eady A. Antimicrobial drugs for treating methicillin-resistant Staphylococcus aureus colonization. Cochrane Database Syst Rev 2003; 2:CD003340.
51. Blank MK, Haas L, Donahoe M, Kramer P, Muto CA. Sustained effect in reducing methicillin-resistant Staphylococcus aureus (MRSA) hospital acquired infections (HAIs) using active MRSA surveillance cultures (MSC)-Three-year follow-up. Paper presented at: 15th Annual Society for Healthcare Epidemiology of America Conference, Los Angeles, California, 2005. Abstract 22.
52. Huang SS, Yokoe DS, Rego VH, et al. Impact of ICU surveillance for MRSA on bacteremia. Paper presented at: 43rd Annual Meeting of The Infectious Diseases Society of America, San Francisco, CA, October 6-9 2005.
53. Thompson R CI, Wenzel R. Epidemiology of nosocomial infections caused by methicillin-resistant Staphylococcus aureus. Ann Intern Med 1982; 97:309-317.
54. Stelfox HT, Bates DW, Redelmeier DA. Safety of patients isolated for infection control. JAMA 2003; 290:1899-1905.
55. Centers for Disease Control and Prevention (CDC). Public health guidance for community-level preparedness and response to SARS. 2004. Available at: http://www.cdc.gov/ncidod/sars/guidance/index.htm. Accessed January 27, 2006.